(Press-News.org) Biogenic amines may be one of the factors responsible for symptoms such as headaches, gastro-intestinal disorders, shortness of breath, fall in blood pressure, and even unconsciousness and cardiac arrhythmia in severe cases. Histamine, one of the best known members of this group, can cause serious physical problems. Biogenic amines can be produced in the body by natural metabolic activities but are also ingested in larger quantities with food. They play a special role in microbiologically produced food such as wine, beer, cheese, and sauerkraut. In a joint project Johannes Gutenberg University Mainz (JGU) and the Dienstleistungszentrum Ländlicher Raum Rheinpfalz (DLR) have developed measures to identify and reduce biogenic amines in wine, where they can be of particular risk to human well-being.
The goal of these investigations was to avoid high concentrations of biogenic amines in wine. The corresponding investigations were performed in the Institute of Microbiology and Wine Research at Mainz University and the Dienstleistungszentrum Ländlicher Raum Rhenish Palatinate in Neustadt in a joint project sponsored by the Research Association of the German Food Industry (FEI). "It is important to make efforts in order to reduce biogenic amines in wine, since this problem shall increase in future," predicts Professor Dr. Helmut König of the JGU Institute of Microbiology and Wine Research (IMW). Compared to other microbiologically processed food such as cheese the concentration of biogenic amines in wine may be low. However, their effect on sensitive human beings may be strongly increased during simultaneous ingestion of wine and other problematic food since alcohol significantly impairs the body's ability to metabolize biogenic amines.
Therefore, Helmut König's team and the enologists of the working group of Ulrich Fischer in Neustadt have developed "Practicable Milestones" in order to enable wine-makers to lower the risk of the production of biogenic amines. There currently is no regulatory requirement regarding the upper limits for biogenic amines in wine. However, in view of the health risks and the need to prevent the development of off-flavors that can be caused by some bacteria, wine-makers shall take measures in respect to cellar and wine producing techniques now. The addressed problems may increase in future as a result of climate change, because higher temperatures will promote the growth of undesirable bacteria on the grapes. It has been shown that the production of biogenic amines will be enhanced due to elevated pH values. An earliness of the ripening period of the grapes may lead to an increase of the pH value of the grape juice.
Preventative and curative measures include the use of tested starter cultures, the early detection of the presence of biogenic amine-forming bacteria by molecular methods and procedures to prevent their growth, for example the application of flash pasteurization or the removal of biogenic amines with the help of bentonite or yeast cell walls. The most economic preventive measure is to lower the pH value by adding tartaric acid. This is already permitted in the warmer climate zones of the EU and in non-European countries, but German wine-makers are currently prohibited to apply this measure. However, in the last years an exemption to this regulation was granted.
### END
Development of measures to prevent wine indispositions
Scientists at Johannes Gutenberg University Mainz and the DLR develop measures to prevent health problems associated with biogenic amines in wine
2012-11-07
ELSE PRESS RELEASES FROM THIS DATE:
Recent studies bring fossils and genes together to piece together evolutionary history
2012-11-07
Paleontology, with its rocks and fossils, seems far removed from the world of developmental genetics, with its petri dishes and embryos. Whereas paleontology strives to determine "What happened in evolution?", developmental genetics uses gene control in embryos to try to answer "How did it happen?" Combined, the two approaches can lead to remarkable insights that benefit both fields.
In the current issue of the Journal of Vertebrate Paleontology, Hans Thewissen, Ingalls-Brown Professor at Northeast Ohio Medical University (NEOMED), and his colleagues review recent studies ...
New method could help communities plan for climate risk
2012-11-07
CAMBRIDGE, Mass. -- Climate scientists cannot attribute any single weather event — whether a drought, wildfire or extreme storm — to climate change. But extreme events, such as Hurricane Sandy, are glimpses of the types of occurrences the world could be more vulnerable to in the future. As the devastation left by Sandy continues to reverberate, decision-makers at every level are asking: How can we be better prepared?
MIT researchers have developed a new tool to help policymakers, city planners and others see the possible local effects of climate change. Its regional projections ...
Synthetic biofilter wins through to the top 'Sweet 16' in Boston
2012-11-07
This press release is available in German.
Months of painstaking work in the laboratory at Bielefeld University's Center for Biotechnology (CeBiTec) have paid off: the 15 students participating in this year's 'international Genetically Engineered Machine competition' (iGEM) at the Massachusetts Institute of Technology (MIT) have good reason to celebrate. The goal of their project was to develop a biological filter that removes estrogen from drinking water. It was a success: they managed to produce enzymes that break down the hormone. On Monday 5 November, the competition ...
Longer use of hormonal contraception during midlife predicts better cognitive function later
2012-11-07
New Rochelle, NY, November 7, 2012—Premenopausal use of hormonal contraceptives may improve the cognitive abilities of women in midlife and for years afterward. This finding may have implications for prevention of declining cognitive function that occurs with advancing age and in diseases such as Alzheimer's. The beneficial effects of hormones increase the longer a woman uses them, as described in a study published in Journal of Women's Health, a peer-reviewed publication from Mary Ann Liebert, Inc., publishers. The article is available free on the Journal of Women's Health ...
Teva to present new Phase III data for QNASL® Nasal Aerosol at the 2012 ACAAI Meeting
2012-11-07
Contact: Denise Bradley
denise.bradley@tevapharm.com
215-591-8974
Teva North America
Teva to present new Phase III data for QNASL® Nasal Aerosol at the 2012 ACAAI Meeting
Studies highlight safety and efficacy profiles in pediatric patients with seasonal allergic rhinitis, reinforce device functionality and reliability and demonstrate ocular safety profile
JERUSALEM, Israel, November 6, 2012 – Teva Pharmaceutical Industries Ltd. announced today that additional data from the Phase III clinical program for QNASL® (beclomethasone dipropionate) Nasal Aerosol will be ...
Bone marrow stem cells do not improve short-term recovery after heart attack
2012-11-07
HOUSTON – (Nov. 7, 2012) – Administering stem cells derived from patients' own bone marrow either three or seven days after a heart attack is safe but does not improve heart function six months later, according to a clinical trial supported by the National Institutes of Health (NIH).
The results of the trial, called Transplantation In Myocardial Infarction Evaluation (TIME), mirror a previous related study, LateTIME, which found that such cells (called autologous stem cells) given two to three weeks after a heart attack did not improve heart function. Both TIME and LateTIME ...
First comprehensive guidelines for managing anaplastic thyroid cancer published in Thyroid journal
2012-11-07
New Rochelle, NY, November 7, 2012—Anaplastic thyroid cancer is a rare form of thyroid tumor, but it is also the most deadly. Newly developed evidence-based recommendations for the diagnosis, treatment, and long-term monitoring and follow-up care of patients with this extremely aggressive form of thyroid cancer are published in Thyroid (http://www.liebertpub.com/thy), a peer-reviewed journal from Mary Ann Liebert, Inc., publishers (http://www.liebertpub.com). The Guidelines, prepared by the American Thyroid Association Anaplastic Thyroid Cancer Guidelines Task Force, are ...
New cell type developed for possible treatment of Alzheimer's and other brain diseases
2012-11-07
Irvine, Calif., Nov. 7, 2012 — UC Irvine researchers have created a new stem cell-derived cell type with unique promise for treating neurodegenerative diseases such as Alzheimer's.
Dr. Edwin Monuki of UCI's Sue & Bill Gross Stem Cell Research Center, developmental & cell biology graduate student Momoko Watanabe and colleagues developed these cells –called choroid plexus epithelial cells – from existing mouse and human embryonic stem cell lines.
CPECs are critical for proper functioning of the choroid plexus, the tissue in the brain that produces cerebrospinal fluid. ...
Study shows how to reduce inappropriate shocks from implanted defibrillators
2012-11-07
MAYWOOD, Il. - Loyola University Medical Center is among the centers participating in a landmark study that could lead to fewer inappropriate shocks from implanted defibrillators.
Implanted defibrillators save lives by shocking hearts back into a normal rhythm. But sometimes a defibrillator can go off when it's not necessary, delivering a shock that feels like a kick in the chest.
The study found that reprogramming defibrillators to be less sensitive to irregular heart rhythms reduced the number of inappropriate shocks, while also reducing mortality. The study was presented ...
Researchers explore connection between popular pain relievers, bladder cancer
2012-11-07
(Lebanon, NH, 11/5/2012) — Dartmouth researchers have found that duration of ibuprofen use was associated with a reduced risk of bladder cancer in patients in northern New England, which has a high mortality rate of this disease. In a 2012 collaborative project with the National Cancer Institute, Margaret Karagas, PhD, co-director, Cancer Epidemiology & Chemoprevention program at Norris Cotton Cancer Center, and Professor of Community and Family Medicine at the Geisel School of Medicine at Dartmouth, and Richard Waddell, D.Sc, Research Assistant Professor of Medicine at ...
LAST 30 PRESS RELEASES:
Here's why seafarers have little confidence in autonomous ships
MYC amplification in metastatic prostate cancer associated with reduced tumor immunogenicity
The gut can drive age-associated memory loss
Enhancing gut-brain communication reversed cognitive decline, improved memory formation in aging mice
Mothers exposure to microbes protect their newborn babies against infection
How one flu virus can hamper the immune response to another
Researchers uncover distinct tumor “neighborhoods”, with each cell subtype playing a specific role, in aggressive childhood brain cancer
Researchers develop new way to safely insert gene-sized DNA into the genome
Astronomers capture birth of a magnetar, confirming link to some of universe’s brightest exploding stars
New photonic device, developed by MIT researchers, efficiently beams light into free space
UCSB researcher bridges the worlds of general relativity and supernova astrophysics
Global exchange of knowledge and technology to significantly advance reef restoration efforts
Vision sensing for intelligent driving: technical challenges and innovative solutions
To attempt world record, researchers will use their finding that prep phase is most vital to accurate three-point shooting
AI is homogenizing human expression and thought, computer scientists and psychologists say
Severe COVID-19, flu facilitate lung cancer months or years later, new research shows
Housing displacement, employment disruption, and mental health after the 2023 Maui wildfires
GLP-1 receptor agonist use and survival among patients with type 2 diabetes and brain metastases
Solid but fluid: New materials reconfigure their entire crystal structure in response to humidity
New research reveals how development and sex shape the brain
New discovery may improve kidney disease diagnosis in black patients
What changes happen in the aging brain?
Pew awards fellowships to seven scientists advancing marine conservation
Turning cancer’s protein machinery against itself to boost immunity
Current Pharmaceutical Analysis releases Volume 22, Issue 2 with open access research
Researchers capture thermal fluctuations in polymer segments for the first time
16-year study finds major health burden in single‑ventricle heart
Disposable vapes ban could lead young adults to switch to cigarettes, study finds
Adults with concurrent hearing and vision loss report barriers and challenges in navigating complex, everyday environments
Breast cancer stage at diagnosis differs sharply across rural US regions
[Press-News.org] Development of measures to prevent wine indispositionsScientists at Johannes Gutenberg University Mainz and the DLR develop measures to prevent health problems associated with biogenic amines in wine



